A substance used in magnetic resonance imaging (MRI) to help make clear pictures of the brain, spine, heart, soft tissue of joints, and inside bones. Gadopentetate dimeglumine is being studied in the diagnosis of cancer. It is a type of contrast agent.
A gadolinium complex of diethylenetriamine pentaacetic acid with ionic paramagnetic properties. Gadopentetate dimeglumine may provide contrast enhancement during magnetic resonance imaging (MRI) of intracranial lesions with abnormal vascularity or of abnormalities in the blood-brain barrier (BBB).